American Healthcare REIT(US:AHR)2026-02-27 21:17Financial Performance - Total revenues for the year ended December 31, 2025, increased to $2,260,123,000, up from $2,070,668,000 in 2024, representing a growth of 9.1%[319] - Resident fees and services revenue for the ISHC segment increased by $144,123,000 in 2025 compared to 2024, driven by higher occupancy and billing rates[320] - The SHOP segment saw an increase of $66,585,000 in resident fees and services revenue for the year ended December 31, 2025, attributed to multiple acquisitions and increased occupancy[321] - For the year ended December 31, 2025, the net income was $70,818,000, compared to a net loss of $35,600,000 in 2024[358] - Normalized FFO attributable to controlling interest for 2025 was $286,489,000, an increase from $184,922,000 in 2024[358] - Net operating income (NOI) for 2025 was $415,160,000, up from $363,536,000 in 2024, reflecting a growth of approximately 14.2%[362] Expenses and Costs - Property operating expenses for the ISHC segment rose to $1,526,933,000 in 2025, representing 86.6% of revenue, compared to 88.3% in 2024[324] - General and administrative expenses increased to $58,735,000 in 2025 from $47,559,000 in 2024, primarily due to higher stock compensation and salaries[326] - Total interest expense decreased to $86,809,000 in 2025 from $126,700,000 in 2024, mainly due to a reduction in debt balances[328] - Interest expense decreased to $85,775,000 in 2025 from $127,730,000 in 2024, indicating improved financial management[362] - Transaction, transition, and restructuring costs amounted to $5,103,000 in 2025, down from $7,141,000 in 2024[358] Impairments and Losses - The company recognized a net loss on dispositions of $2,965,000 for the year ended December 31, 2025, compared to a net gain of $5,213,000 in 2024[329] - Impairment charges for real estate investments totaled $49,935,000 in 2025, an increase from $45,755,000 in 2024[330] - The company experienced an impairment of real estate investments of $49,935,000 in 2025, compared to $45,755,000 in 2024[358] - The loss on dispositions of real estate investments was $2,965,000 in 2025, a recovery from a gain of $5,213,000 in 2024[358] Cash Flow and Financing - Cash flows from operating activities increased to $294,441,000 in 2025, up from $176,087,000 in 2024, primarily due to improved resident occupancy and increased billing rates[341] - Net cash used in investing activities increased by $824,073,000 in 2025, primarily due to cash paid for acquiring senior housing properties[342] - The company transitioned from net cash used in financing activities in 2024 to net cash provided by financing activities of $817,241,000 in 2025[343] - Distributions for the year ended December 31, 2025, totaled $161,893,000, with 68.8% classified as return of capital[344] - The weighted average effective interest rate on outstanding debt was 4.34% per annum as of December 31, 2025[349] Company Structure and Management - The company operated through four reportable segments as of December 31, 2025: ISHC, OM, SHOP, and triple-net leased properties[316] - The company appointed Jeffrey T. Hanson as Interim Chief Executive Officer effective February 3, 2026, following the leave of absence of the previous CEO[363] Assets and Obligations - As of December 31, 2025, the company’s properties were 91.3% leased, with 6.6% of the leased GLA scheduled to expire in 2026[313] - As of December 31, 2025, the company had $12,085,000 of restricted cash for capital expenditures and estimated capital and tenant improvement expenditures of approximately $91,816,000 for 2026[335] - The total contractual obligations as of December 31, 2025, amounted to $2,253,590,000, with fixed-rate debt principal payments of $985,565,000[336] - The company had an aggregate borrowing capacity of $1,200,000,000 under its credit facilities, with $550,000,000 outstanding and $650,000,000 available as of December 31, 2025[339] Equity and Valuation - For the year ended December 31, 2025, the company recognized a gain of $14,580,000 on re-measurement of previously held equity interests, compared to no gain in 2024[331] - The company reported a $23,001,000 reversal of valuation allowances against net deferred tax assets due to increased taxable income from its taxable REIT subsidiaries[332] - The non-cash impact of changes to equity instruments was $14,621,000 in 2025, compared to $9,367,000 in 2024, indicating increased volatility in equity holdings[358]